𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of accelerated split-course radio-chemotherapy in unresectable head & neck carcinomas

✍ Scribed by Thomas G. Wend; Thomas P.U. Wustrow; Reiner Hartenstein; Klaus-Rüdiger Trott

Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
113 KB
Volume
13
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot trial of concomitant chemotherapy
Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck
✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; João V. Salvajoli; Andrew J. Si 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

Feasibility and early results of acceler
Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly
✍ Abdelkarim S. Allal; Daphné Maire; Minerva Becker; Pavel Dulguerov 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## BACKGROUND. Accelerated radiotherapy (RT) represents a promising method with which to improve the treatment outcome in patients with head and neck carcinoma. However, its applicability to elderly patients has not been well established. This study assessed treatment toxicities, patient complianc

A prospective phase ii trial of concomit
A prospective phase ii trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck
✍ Louis B. Harrison; Adam Raben; David G. Pfister; Michael Zelefsky; Elliot Strong 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

Background. Our study is a prospective evaluation of unresectable malignant cancers of the head and neck treated with concomitant chemotherapy and radiotherapy (RT) using delayed accelerated fractionation (concomitant boost). Methods: Between January 1988 and March 1995, 82 patients with unresectab

Toxicity and survival outcomes of hyperf
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers
✍ John M. Watkins; Keisuke S. Shirai; Amy E. Wahlquist; Robert K. Stuart; Uzair B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract ## __Background__. Reirradiation of locoregionally recurrent, previously irradiated head/neck cancer may be considered in situations of unresectability, medical inoperability, or adverse pathologic features found at salvage resection. ## __Methods__. Retrospective cohort analysis of